GenBio AI
Technology
Nobel laureate's startup builds the first virtual human cell
Drug discovery has a long-standing and expensive flaw. Only about one in 10,000 compounds entering preclinical pipelines ever reaches the clinic, a failure rate that has resisted every wave of laboratory automation for decades.